Processa Pharmaceuticals, Inc. current report, 10 September 2015

SEC Filing Summary: Heatwurx, Inc. (Form 8-K)

Business Context and Reporting Period

This Current Report on Form 8-K was filed by Heatwurx, Inc., a Delaware corporation, on September 10, 2015. The report addresses a material event occurring on September 3, 2015, regarding the termination of the company's relationship with its independent auditor, Hein and Associates, LLP.

Financial Metrics

The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and auditor changes rather than financial performance.

Material Changes

  • Auditor Dismissal: On September 3, 2015, the Company was notified by Hein and Associates, LLP that their auditor/client relationship had ceased.
  • Unexpected Termination: The Company stated it had not been previously informed by Hein of a desire to terminate the relationship prior to receiving the notification letter.
  • No Disagreements: The Company reported no disagreements with Hein regarding accounting principles, financial statement disclosures, or auditing scope/procedures that would have required reference in the auditor's report.
  • No Reportable Events: There were no reportable events as defined in Regulation S-K Item 304(a)(1)(v) from the Company's inception through September 3, 2015.

Guidance, Outlook, and Risks

The filing contains no management commentary on future guidance, outlook, or specific financial risks. The primary risk disclosed is the loss of the independent auditor, though the Company asserts the departure was not due to accounting disputes.

Key Facts for Investor Verification

  • Verify the identity and qualifications of the new independent auditor selected to replace Hein and Associates, LLP.
  • Confirm the effective date of the new auditor's engagement and the scope of their initial review.
  • Review subsequent filings to ensure the auditor change does not impact the timeliness or accuracy of future financial reporting.
  • Investigate the underlying reasons for the auditor's departure, despite the Company's statement of no disagreements.